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Background: To evaluate the association between fasting glucose levels in women throughout pregnancy and the
occurrence of gestational diabetes mellitus (GDM) and other pregnancy complications, macrosomia, and cesarean
delivery.
Methods: An analytical cross-sectional study with 829 healthy pregnant women receiving health care at a public
maternity unit in Rio de Janeiro between 1999 and 2008. The dependent variables assessed in the study were: GDM
(was confirmed when two or more values were above the glucose curve using 100 g glucose), complications, mode
of delivery and birth weight. Macrosomia was defined as a birth weight of >4000 g. The independent variables
assessed were: maternal fasting glucose per trimester as a continuous variable, divided into three categories,
socio-demographic data on the mothers. The level of statistical significance was set at 5%.
Results: The mean fasting glucose levels of the women who had GDM were higher in the second trimester than
for those who had no pregnancy complications (90.5 mg/dL vs. 78.5 mg/dL, p = 0.000). Higher mean fasting
glucose levels were also found in the third trimester for women who developed GDM than for those with no
pregnancy complications (90 mg/dL vs. 77.8 mg/dL, p = 0.016). Women who had a cesarean delivery had higher
fasting glucose levels in the second (80.4 mg/dL vs. 78 mg/dL, post hoc = 0.034) and third (80.4 mg/dL and
77.1 mg/dL; post hoc = 0.005) trimesters than women who had a normal delivery. Also, higher fasting glucose levels
were found in the second semester for women whose infants had macrosomia than for women whose newborns
were normal weight (86.2 mg/dL and 78.8 mg/dL; post hoc = 0.003). The chance of develop GDM was higher for
the women with glucose levels in the 90–94 mg/dL range in the second trimester (OR = 7.2; 95% CI = 2.33-22.24)
than for the women whose glucose levels were in the <80 mg/dL and 80-90 mg/dL ranges.
Conclusion: Second and third trimester fasting glucose levels below the cut-off values for the diagnosis of GDM
are associated with an increased risk of pregnancy complications. The dependent variables assessed in the study
were: GDM (present/absent), complications, mode of delivery (normal, forceps, cesarean), and birth weight.
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There is a consensus in the literature that pregnant
women with gestational diabetes mellitus (GDM) are
more likely to have adverse perinatal outcomes, such as
fetal macrosomia, the need for a surgical delivery, and
birth injuries. Furthermore, such women are more likely
to develop diabetes mellitus in the future, which is seen
in between 20% and 50% of such cases up to ten years
after childbirth [1-3]. However, this risk is disputed
when maternal glucose is found to be high, but not high
enough to be diagnosed as GDM [4,5].
GDM is defined as any degree of glucose intolerance
with onset or first recognition during pregnancy [2]. The
prevalence of GDM in adult women (>20 years of age)
receiving health care from the Brazilian public health
system, according to the previous diagnostic criteria set
forth by the World Health Organization (WHO), was
7.6% in the 1980 s [6,7].
The Hyperglycemia and Adverse Pregnancy Outcomes
[4] (HAPO) multicenter study was pioneering for demon-
strating an association between moderately higher levels
of maternal glucose and perinatal complications. A signifi-
cant and rising likelihood of fetal macrosomia, the need
for delivery by caesarean section, umbilical cord C-
peptide, and neonatal hypoglycemia, was found to be
associated with increased maternal glucose levels [4].
The following year, Riskin-Mashiah et al. [5] also pub-
lished a study that demonstrated an association between
fasting glucose levels in the first trimester and the pro-
gressively increased occurrence of pregnancy complica-
tions and adverse outcomes: GDM, fetal macrosomia,
and the need for delivery by cesarean section.
In a retrospective cross-sectional study, a significant
association was found between GDM risk factors or ele-
vated glucose levels at the first antenatal visit and the
occurrence of the following outcomes: large for gesta-
tional age, increased indication of cesarean delivery, and
preterm birth [8].
In the light of new evidence that shows there is an asso-
ciation between maternal glucose concentrations below
the cut-off points for the diagnosis of GDM and adverse
outcomes, a new proposal for the diagnosis of GDM was
recommended in 2010 by the International Association of
Diabetes and Pregnancy Study Groups (IADPSG) [9] and
endorsed by the WHO [2].
The most common complications affecting maternal
and fetal health associated with GDM are fetal macro-
somia and the need for a surgical delivery. Macrosomia
increases the chance of complications like systemic
hypertension, preterm birth, infections, intrauterine
death, shoulder dystocia, fractured clavicle and hu-
merus, and other birth injuries [10,11]. Meanwhile,
cesarean deliveries have been associated with compli-
cations such as the increased chance of infections, theneed for blood transfusions, pneumonia, the increased
risk of respiratory distress in the newborn [12], and a
three times higher chance of breastfeeding being ter-
minated after 30 days of life because of the need for
artificial incubation [13].
The aim of this study was to analyze the association be-
tween maternal glucose levels during pregnancy and the
development of pregnancy complications (e.g. anemia,
pregnancy-induced hypertension [PIH], urinary tract in-
fections, premature amniorrhexis, GDM), fetal macroso-
mia, and surgical delivery (forceps or cesarean) in adult
women who screened negative for diabetes mellitus.
Methods and study design
This analytical cross-sectional study [14] is based on
data from a study at a public maternity unit in Rio de
Janeiro/Brazil. The unit provides outpatient antenatal
services for low- and high-risk pregnancies, and free care
for pregnant adults and adolescents who live in the state
of Rio de Janeiro. The antenatal care is provided by a
multi-disciplinary team that includes obstetricians, nutri-
tionists, nutrologists, nurses, psychologists, psychiatrists,
social workers and other professionals.
The population under study was made up of adult
pregnant women and recent mothers who received
health care between 1999 and 2008. Specifically, they
were women and their respective newborns who re-
ceived health care at the maternity unit in question at
three different periods: 225 from April 1999 to December
2001; 227 from June 2005 to September 2006, and 394
from September 2007 to September 2008. Of this ori-
ginal total of 846 women, 829 met the inclusion criteria,
namely: having received antenatal care and/or given
birth at the maternity unit under study; aged ≥20;
singleton pregnancy; no chronic diseases prior to preg-
nancy; plasma glucose screened and recorded through-
out pregnancy.
The number of pregnant women accompanied by trimes-
ter of pregnancy was 317 in the first trimester, 288 and 224
in the second and third trimesters respectively.
Maternal plasma glucose was measured using the glu-
cose oxidase method, and cases of GDM were identified
using the criteria valid during the period in question.
When a glucose level of ≥ 130 mg/dL was obtained
1 hour after the oral glucose tolerance test (OGTT) with
50 g (screening test), the pregnant women were referred
to conduct another OGTT with 100 g anhydrous glucose
1 h, 2 h and 3 h after ingestion. GDM were confirmed
when two or more values were greater than or equal to
95 mg/dL (fasting), 180 mg/dL (1 h), 155 mg/dL (2 h),
140 mg/dL (3 h) [15,16].
As well as fasting plasma glucose, other maternal char-
acteristics studied included GDM, anemia, PIH, urinary
tract infection, and premature amniorrhexis.
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socio-demographic and obstetric characteristics, anthropo-
metric data, and details on the antenatal care received
(number of prenatal medical visits, and number of ante-
natal visits with a nutritionist).
The neonatal conditions evaluated were weight at
birth, with underweight being <2500 g, normal weight
being 2500 g to 3990 g, and overweight being ≥4000 g,
irrespective of gestational age [17].
The maternal characteristics, information about ante-
natal care, pregnancy complications, and neonate char-
acteristics were identified by consulting the opinions
issued by the antenatal team and/or by interpreting the
results of the exams in the women’s medical records,
which was done by a trained, supervised team.
The dependent variables assessed in the study were:
GDM (present/absent), complications, mode of delivery
(normal, forceps, cesarean), and birth weight.
The independent variables assessed were: maternal
fasting glucose per trimester as a continuous variable, di-
vided into three categories: <80 mg/dL, 80-90 mg/dL
and 90- 94 mg/dL; socio-demographic data on the
mothers (age, education, marital status, basic sanitation
conditions, total household income); anthropometric
data (pre-pregnancy BMI and weight, weight gain per
trimester, total weight gain); and antenatal care. The
basic sanitation conditions were considered adequate
when the women’s homes had piped, treated water, sew-
erage, and regular waste collection; they were deemed
inadequate in the absence of any of these services.
Pregnancy complications were identified from the
medical records and by interpreting exams. Anemia was
diagnosed when hemoglobin levels were <11 g/dL at any
time during pregnancy [18]. PIH was identified when
blood pressure after the twentieth week of pregnancy
was ≥140 × 90 mmHg. Women diagnosed as having
hypertension were also investigated for the presence of
proteinuria, with >300 mg protein in urine in 24 h being
interpreted as indicative of preeclampsia, and this value
in association with seizures as being eclampsia. Other
complications, like urinary infection and premature rup-
ture of membranes, were identified by consulting the
medical records [18,19].Statistical analyses
To evaluate the quality of the data, the concordance of
the responses obtained by two different researchers was
measured, based on the information they collected from
the same medical records from the cohorts from 1999
(n = 35) and 2005 (n = 28) [20]. The statistics used for
this analysis were intraclass correlation coefficient (ICC)
and kappa (k), with ICC and k > 0.61 being taken to indi-
cate good concordance [20].An exploratory data analysis was conducted, the means
and standard deviation (SD) were calculated, Student’s
t-test, ANOVA and post-hoc Tukey test were per-
formed, and Levene’s test was used to test homogeneity
of variance. The level of statistical significance was set
at 5%. Women who developed GDM in the second tri-
mester were excluded from the analyses of the mean fast-
ing glucose levels in the third trimester of pregnancy.
Bivariate analysis was used to evaluate the association
between the dependent and independent variables using
the chi-squared test, considering p < 0.05. Next, logistic
regression models were tested to identify the predictors
of the dependent variables (adverse outcomes – GDM,
cesarean delivery, and fetal macrosomia). Logistic regres-
sion was used to estimate the odds ratios for the out-
comes evaluated with a confidence interval (CI) of 95%.
The forward stepwise method was used to adjust the
multivariate model, with p-values of 0.05 and 0.10 for
entry and exit, respectively, to test all the independent
variables. Only those variables with p < 0.05 were kept in
the final model. All the analyses were conducted using
SPSS for Windows, version 17.0.
The original study that yielded the database for this
article was designed in compliance with resolution 196/96
of the National Health Council (Conselho Nacional de
Saúde; Brasil, 1996). It was approved by the research
ethics committee of the National School for Public
Health, Fundação Oswaldo Cruz (opinion #75/02), and
by the ethics committee of Instituto de Puericultura e
Pediatria Martagão Gesteira at the Federal University of Rio
de Janeiro (UFRJ) on December 14, 2004 (opinion # 35/04)
and the research ethics committee of the maternity
unit, Maternidade Escola da UFRJ on October 8, 2008
(CEP – 0013.0.361.000-08).
Results
In this study, three cohorts of pregnant women who re-
ceived care in different time periods at the maternity
unit in question were studied. As over the periods stud-
ied, some changes took place in the number of visits to
the nutritionist during antenatal care, the impact of nu-
tritional supervision (yes/no) on the outcomes of interest
in this study was evaluated, namely: mode of delivery
(normal/cesarean; p = 0.172); weight at birth (underweight
and normal weight/macrosomia; p = 0.807); neonatal com-
plications (yes/no; p = 0.357); pregnancy complications
(yes/no; p = 0.919). The differences between mean mater-
nal glucose levels in the second trimester (with nutritional
supervision – 79.79 mg/dL; without nutritional supervi-
sion – 78.99 mg/dL; p = 0.234) and the third trimester
(with nutritional supervision – 79.56 mg/dL; without nu-
tritional supervision – 77.91 mg/dL; p = 0.121) were also
investigated. In view of the results obtained, the data ana-
lysis was done on the sum of women from the cohorts in
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tween them.
In the data quality evaluation, good inter-rater concord-
ance indices were found, and it was also found that the
procedures for obtaining the information were the same
for both groups. The values calculated were ICC >0.92
and k >0.65 [20].
The average age of the women was 27.6 (SD = 5.2);
35.4% had white skin, 97.2% lived in housing with ad-
equate basic sanitation, and 32.4% had completed
12 years of schooling. In the anthropometric evaluation,
the average pre-pregnancy BMI was found to be 23.7 kg/m2
(n = 782; SD = 8.1). Most of the women (63.8%) were clas-
sified as normal weight at the start of pregnancy, and
38.4% had adequate total weight gain during pregnancy,
according to Institute of Medicine criteria (Table 1) [17].
The mean fasting glucose levels in the first, second
and third trimesters were 79.1 mg/dL (n = 337; SD = 10.2),
79.3 mg/dL (n = 499; SD = 10.8) and 78.8 mg/dL (n = 414;
SD = 10.5), respectively.
The women had an average of 8.2 antenatal consulta-
tions with an obstetrician (n = 825; SD = 2.3), and 1.7Table 1 Characteristics of the women and their newborns
(Rio de Janeiro, Brazil - 1999 and 2008)
Characteristic N %
Pre-pregnancy nutritional status (BMI)
Underweight (<18.5 kg/m2) 84 10.9
Normal weight (18.5 – 24.99 kg/m2) 494 63.8
Overweight (25.0 – 29.99 kg/m2) 131 16.9








Cesarean section 270 46.6
Gestational age at birth
Preterm (<37 weeks) 26 4.7
Term (≥37 weeks) 527 95.3
Weight at birth
Low (<2500 g) 33 4.3
Normal (2500 g - 3999 g) 695 91.1




Gestational diabetes mellitus 27 3.3antenatal consultations with a nutritionist (n = 827;
SD = 2.1). The average gestational age at birth was
39.1 weeks (n = 743; SD = 1.6) and the average weight
of the newborns was 3.2 kg (n = 764; SD = 4.8).
Table 1 shows the characteristics of the pregnancies,
deliveries and postpartum periods. It shows that 54.9%
of the women had no pregnancy complications, and
49.6% had a vaginal delivery; 95.3% of the infants were
term births, and 4.6% had macrosomia. Further, it was
found that 3.3% (n = 27, Table 1) of the women studied
developed GDM. The other pregnancy complications
observed were anemia (n = 191; 23%), PIH (n = 40; 4.8%),
premature amniorrhexis (n = 65; 7.8%), and urinary tract
infection (n = 23; 2.8%).
A significant association was found between maternal
glucose levels in the second (p = 0.000) and third (p =
0.016) trimesters and the development of GDM (Table 2).
The mean fasting glucose levels were higher amongst
the group who developed GDM (second trimester:
90.5 mg/dL; third trimester: 90 mg/dL) than amongst
women who did not have any complications during
pregnancy (second trimester: 78.5 mg/dL; third trimes-
ter: 77.8 mg/dL).
As Table 3 shows, a significant association was found
between maternal fasting plasma glucose concentrations
in the second trimester and two outcomes: weight at
birth (p = 0.005) and mode of delivery (p = 0.039). Sig-
nificantly higher mean glucose levels were found for the
mothers of the infants with macrosomia than for the
mothers of the normal weight infants (86.2 mg/dL and
78.8 mg/dL, respectively, p = 0.003). Likewise, higher
mean glucose levels were found for the women who had
a cesarean section than for those who had a vaginal deliv-
ery (80.4 mg/dL and 78.0 mg/dL, respectively, p = 0.034).
Women who had a cesarean section were also found to
have higher mean fasting glucose levels in the third tri-
mester than those who had a normal delivery (80.4 mg/dL
and 77.1 mg/dL, respectively, p = 0.005, Table 3).
Maternal fasting plasma glucose levels were divided
into three ranges (<80 mg/dL, 80-90 mg/dL and 90-
94 mg/dL), and categorized per trimester of pregnancy,
then related to the adverse outcomes under study. This
analysis could not be done for fasting plasma glucose in
the first trimester because of the limited number of obser-
vations of this variable in the different ranges studied.
Most of the women evaluated in the first trimester of
pregnancy (53%) had fasting glucose levels of <80 mg/dL.
The percentage of the three maternal fasting glucose
concentration ranges in the second trimester were:
58.3% <80 mg/dL, 28.5% 80-90 mg/dL, and 13.2% 90-
94 mg/dL. The probability by risk of GDM was higher
amongst the women in the 90- 94 mg/dL range (OR =7.2;
95% CI =2.33-22.24) than it was for the women with lower
levels (see Table 4). No association was found between the
Table 2 Maternal fasting plasma glucose levels per trimester and pregnancy complication (Rio de Janeiro, Brazil - 1999
and 2008)
Complication Fasting plasma glucose in the first
trimester (mg/dL)
Fasting plasma glucose in the second
trimester (mg/dL)
Fasting plasma glucose in the third
trimester (mg/dL)a
n Mean SD p n mean SD p n mean SD p
None 196 79.3 9.3 0.479 270 78.5 9.8 0.000 220 77.8 9.6 0.016
GDM 1 86 - 18 90.5 21.3 4 90 19.4
aFasting plasma glucose in the third trimester.
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cations macrosomia and cesarean delivery for the second
trimester of pregnancy (Table 4).
In the third trimester, 62.5% of the women had fasting
plasma glucose levels of <80 mg/dL; 29% fell into the
80-90 mg/dL category, and 8.5% in the 90–94 mg/dL
category. No association was found between the plasma
glucose ranges studied and the pregnancy complications
and outcomes studied (GDM, macrosomia, cesarean de-
livery) for the third trimester of pregnancy (Table 4).
Discussion
GDM can have negative effect on maternal and newborn
health. Therefore, reducing the risk of perinatal morbid-
ity and mortality from pregnancy complications is a
focus of study in modern obstetrics [2]. This study
showed that even when second and third trimester fast-
ing glucose is below the established cut-off values for
the diagnosis of GDM, it is associated with an increased
risk of pregnancy complications as macrosomia, GDM
and cesarean section.
In the HAPO study [4], a significant association was
found between increasing maternal fasting plasma glucose
concentrations in the second trimester, and the increased
occurrence of fetal macrosomia, need for surgical delivery,
neonatal hypoglycemia, and preeclampsia [4,5]. In the an-
thropometric evaluation of the pregnant women in theTable 3 Maternal fasting plasma glucose levels per trimester,
Brazil - 1999 and 2008)
Weight at birth
(Kg)




N Mean SD p N Mean
Underweight 9 76.1 10.2 0.585 15 78.7
Normal 286 79.3 10.3 412 78.8
High (macrosomia) 15 78 7.6 24 86.2
Post-hoc (p) 86.2 >
Mode of delivery
Vaginal 173 78.8 9.4 0.582 244 78.0
Cesarean 139 79.4 11.0 218 80.4
Forceps 15 76.6 12.6 18 77.9
Post-hoc (p) 80.4 >
p = Post-hoc.
aFasting plasma glucose in the second trimester; bfasting plasma glucose in the thirHAPO study, their average pre-pregnancy BMI was
27.7 kg/m2, and most of them were overweight at onset
of pregnancy. A sub-analysis was carried out on the
same cohort [21] to evaluate whether GDM and mater-
nal obesity were associated individually or jointly with
adverse fetal outcomes or maternal complications. It
was found that women with GDM who were not obese
were more at risk of having outcomes such as fetal
macrosomia, shoulder dystocia or birth injury, a higher
percentage of body fat in the newborns, and a higher
concentration of cord-blood serum C-peptide than the
obese women without GDM. Our cohort had a higher
prevalence of normal weight women, which reinforces
the importance of high maternal glucose as a risk factor
for adverse pregnancy outcomes.
Alongside pre-pregnancy BMI, we found other differ-
ences between the cohorts of the HAPO study [4] and
this study. For instance, average maternal age, mean
fasting glucose levels at different stages of pregnancy,
and prevalence of PIH were all higher in the HAPO
study [4].
The higher prevalence of PIH and fetal macrosomia in
the HAPO study [4] could be attributed to the higher
prevalence of pre-pregnancy overweight in that study
than in ours. The association between maternal over-
weight/obesity and both PIH and macrosomia has been
described in other studies [22,23].birth weight and mode of delivery (Rio de Janeiro,
ma glucose in the second
g/dL)
Fasting plasma glucose in the third
trimester (mg/dL)
SD p N Mean SD p
12.3 0.005 8 82.6 14.7 0.545
9.9 342 78.7 10.6
19.7 21 80 11.6
78.8 (0.003)
9.3 0.039 194 77.1 10.0 0.007
11.5 193 80.4 10.9
12.5 15 80.1 11.4
78.0 (0.034)ª 80.4 > 77.1 (0.005)b
d trimester.
Table 4 Maternal fasting plasma glucose levels in the second and third trimesters, divided into three ranges, and
outcomes (Rio de Janeiro, Brazil - 1999 and 2008)
Fasting glucose (mg/dL) n (%) GDM n (%) OR (95% CI) Macrosomia n (%) OR (95% CI) Cesarean section n (%) OR (95% CI)
2nd Trimester
<80 168 (58.3) 6 (3.6) 1.0 10(3.9) 1.0 110 (40.7) 1.0
80-90 82 (28.5) 4 (4.9) 1.38 (0.38-5.04) 8 (5.7) 1,33 (0.50-3.51) 77 (51.3) 1.36 (0.89-2.08)
90-94 38 (13.2) 8(21.1) 7.2 (2.33-22.24) 6(10.9) 2.03 (0.65-6.33) 31 (51.7) 1.19 (0.66-2.16)
3rd Trimester
<80 140 (62.5) 1 (0.7) 1.0 13(6.0) 1.0 104 (45.2) 1.0
80-90 65 (29) 2 (3.1) 4.4 (0.39-49.56) 5 (4.6) 0.73 (0.25-2.13) 60 (49.6) 1.24 (0.77-1.98)
90-94 19 (8.5) 1(5.3) 7.7 (0.46-128.9) 3 (6.7) 0.77 (0.16-3.62) 29 (58.0) 1.86 (0.95-3.65)
OR: odds ratio; 95% CI: 95% confidence interval.
Adjusted for the following variables: maternal age, parity, pre-pregnancy BMI.
With women diagnosed as having GDM in the second trimester excluded from the analysis of the third trimester.
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were calculated for each trimester of pregnancy. A simi-
lar approach was taken in a study of 6129 women from
June 2001 to June 2006 [5]. In that study, the authors
assessed the association between maternal fasting glu-
cose levels in the first trimester of pregnancy and certain
adverse outcomes, including fetal macrosomia, surgical
delivery and GDM. They divided fasting glucose into
seven ranges: <75 mg/dL, 75-79 mg/dL, 80-84 mg/dL,
85-89 mg/dL, 90-95 mg/dL, 95-99 mg/dL, 100-105 mg/
dL. It was found that the higher the maternal fasting
glucose level, the greater the likelihood of perinatal com-
plications. The risk of GDM, fetal macrosomia, and de-
livery by cesarean section was higher for the women
whose fasting glucose was 80-84 mg/dL in the first tri-
mester [5].
In this study, we found that fasting glucose levels in
the second trimester above 90.5 mg/dL, 86.2 mg/dL and
80.4 mg/dL were potential markers by factors of GMD,
macrosomia and cesarean section, respectively.
Another study that has demonstrated an association
between maternal glucose below the classic cut-off values
for the diagnosis of GDM and adverse pregnancy out-
comes involved 14036 women diagnosed as not having
GDM, but with one elevated glucose value in the oral tol-
erance test. The study demonstrated increased rates of
cesarean deliveries, fetal macrosomia (weight ≥4000 g),
preeclampsia, and admissions to neonatal intensive care
units [24] for this group than for the women whose test
values were all normal.
An uncontrolled study conducted between 2000 and
2009 evaluated the frequency of adverse pregnancy and
neonatal outcomes in women with positive screening
(fasting plasma glucose ≥ 90 mg/dL and/or risk factors
for GDM) but negative diagnostic test for GDM (gly-
cemic index 3 h after 100 g glucose intake anhydrous
under two cutoff points above normal values for the
diagnosis of GDM). It reported similar data to the otherstudies, such as cesarean deliveries in 62.3% of the
women studied, 14.2% preterm deliveries, and 19.3%
newborns classified as large for gestational age [8].
The plasma glucose ranges associated with the out-
comes studied were consistent with those published in a
new diagnosis proposed by the IADPSG in 2010, reinfor-
cing the need for further studies into the influence of
maternal plasma glucose concentrations and the gesta-
tional period in which these are most related to the oc-
currence of adverse pregnancy outcomes.
The study showed that maternal glucose levels in the
second trimester of pregnancy were associated with the
risk of developing complications such as GDM. It was
demonstrated that fasting glucose testing, an easy, low-
cost exam, has great potential for the early detection of
women at risk of having more adverse perinatal out-
comes, irrespective of the presence of other risk factors,
such as obesity and maternal age.
The findings were very important and corroborate
those already in the literature on the subject in question.
Emphasized the need for earlier onset of possible pre-
natal care for the screening and diagnosis of GDM for
all pregnant women for the prevention of the conse-
quences of this.
The maternal glycemia, even below the classically consid-
ered values for the diagnosis of GDM in Brazil, appeared as
a short and long-term risk factor for the health of the
mother and her son, demonstrating the importance of re-
ducing the cutoff points for the diagnosis of GDM consoli-
dated by IADPSG [9] and the ADA [1], at the earliest
assessment of these women in prenatal care. The gesta-
tional periods in which maternal blood glucose had greater
influence on the appearance of complications were the
second and third quarters, indicating the need for care fur-
ther enhanced in these vulnerable periods, since they are
related to intensive development phase and fetal growth.
This study has some limitations that should be consid-
ered: the cross-sectional research design does not allow
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investigated, and the sample size is smaller than in the
other studies investigating the topic.
Conclusion
Even when second and third trimester fasting glucose is
below the established cut-off values for the diagnosis of
GDM, it is associated with an increased risk of preg-
nancy complications. Thus, this study with other litera-
ture on the subject, point to the need of the earliest
possible start of prenatal care for the screening and diag-
nosis of GDM for all pregnant women including those
considered as low risk pregnancy, for the prevention of
consequences of this.
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